Concourse Financial Group Securities, Inc. Titan Pharmaceuticals Inc Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share
Q4 2023 Feb 07, 2024	BUY	$0.26 - $0.48 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$0.45 - $0.66 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$0.45 - $0.66 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$0.65 - $0.82 $0 - $0
Q1 2023 May 15, 2023	BUY	$0.73 - $1.05 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$0.77 - $22.8 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$0.53 - $22.6 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$0.38 - $0.94 $0 - $0
Q1 2022 May 09, 2022	BUY	$0.89 - $1.26 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$1.02 - $1.93 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$1.87 - $2.57 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$2.24 - $2.9 $0 - $0
Q1 2021 May 13, 2021	BUY	$2.66 - $4.23 $0 - $0
Q4 2020 Feb 02, 2021	BUY	$3.0 - $6.0 $0 - $0

Others Institutions Holding TTNP

# of Institutions

Shares Held

Call Options Held

Put Options Held

American Portfolios Advisors Holbrook, NY

23
Shares

$77
0.0% of portfolio

View Full List

About TITAN PHARMACEUTICALS INC

Ticker TTNP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,629,200
Market Cap $49.4M
Description
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in Canada and the Euro...

More about TTNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account